CJ holds preliminary ceremony to launch Exone

Published: 2013-09-06 06:57:00

Updated: 2013-09-06 06:57:00

The pharmaceutical unit of CJ CheilJedang, the country’s largest food manufacturer, on Tuesday held an in-house ceremony in Seoul ahead of its launching of Exone, an incrementally modified drug (IMD) of Swiss based Novartis’s Exforge (valsartan and amlodipine besylate), as part of moves to build ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK